Orthofix Medical Inc. Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent
Orthofix Medical Inc. (OFIX) reported Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent of -$3.83 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent · last filed 2015-04-29
- Orthofix Medical Inc. other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2014 was -$3.83M.
- Orthofix Medical Inc. other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2013 was -$2.15M, a 239.04% decline from fiscal 2012.
- Orthofix Medical Inc. other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2012 was $1.55M.
- Orthofix Medical Inc. other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2011 was -$2.59M.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|
| 2014-12-31 | -$3.83M 10-K · filed 2015-04-29 | |
| 2013-12-31 | -$2.15M 10-K · filed 2015-04-29 | -$2.21M 10-K · filed 2014-03-31 |
| 2012-12-31 | $1.55M 10-K · filed 2015-04-29 | $896.00K 10-K · filed 2013-03-01 |
| 2011-12-31 | -$2.59M 10-K/A · filed 2015-03-31 | -$3.88M 10-K · filed 2013-03-01 |
| 2010-12-31 | -$1.44M 10-K/A · filed 2014-03-24 | -$1.84M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |